Q4 2023 Holdings
Filed 2024-02-14 | 41 holdings | $642.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $127.6M | 6,788,609 | 19.9% |
| Rayzebio Inc | COM | 75525N107 | $114.8M | 1,845,948 | 17.9% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $95.4M | 4,121,689 | 14.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $38.9M | 4,519,361 | 6.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $25.6M | 460,441 | 4.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $24.6M | 1,267,790 | 3.8% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $22.2M | 8,459,314 | 3.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $18.9M | 2,868,035 | 2.9% |
| Acelyrin Inc | COM | 00445A100 | $18.8M | 2,523,022 | 2.9% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $15.2M | 1,458,875 | 2.4% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $14.6M | 2,780,261 | 2.3% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $13.9M | 1,786,427 | 2.2% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $13.7M | 967,527 | 2.1% |
| Hillevax Inc | COM | 43157M102 | $12.8M | 799,274 | 2.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.1M | 850,000 | 1.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $7.9M | 172,647 | 1.2% |
| Sutro Biopharma Inc | COM | 869367102 | $7.2M | 1,675,579 | 1.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $6.9M | 347,500 | 1.1% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $6.8M | 3,640,015 | 1.1% |
| Inozyme Pharma Inc | COM | 45790W108 | $6.7M | 1,562,500 | 1.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $6.2M | 630,000 | 1.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.6M | 6,130,268 | 0.9% |
| Immatics N.v(IMTX) | SHS | N44445109 | $4.2M | 396,000 | 0.6% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $4.2M | 470,304 | 0.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $3.9M | 360,414 | 0.6% |
| Pepgen Inc(PEPG) | COM | 713317105 | $3.0M | 436,813 | 0.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $2.9M | 196,425 | 0.4% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $2.8M | 669,303 | 0.4% |
| Rain Oncology Inc | COM | 75082Q105 | $2.4M | 2,034,552 | 0.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.3M | 202,348 | 0.2% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $1.3M | 154,664 | 0.2% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $1.2M | 1,049,153 | 0.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $731.0K | 696,171 | 0.1% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $470.2K | 40,888 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $469.8K | 172,089 | 0.1% |
| Viracta Therapeutics Inc | COM | 92765F108 | $393.1K | 689,709 | 0.1% |
| Science 37 Holdings Inc | COM NEW | 808644207 | $240.3K | 45,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $97.7K | 78,131 | 0.0% |
| Allovir Inc | COM | 019818103 | $56.0K | 82,336 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $8.0K | 133,333 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $1.9K | 99,999 | 0.0% |